RxDoctor Payments Data

Ali Ghorbanifarajzadeh, DPM

Primary Podiatric Medicine · Bakersfield, CANPI 1164824249

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $11,896 of the $16,880 with a category attached, or 70.5%. It is spread thinly across 20 manufacturers, the largest accounting for just 21.4%. Reporting peaked in 2022 at $5,738 and has fallen 96.4% since, to $208 in 2025. Among primary podiatric medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,880in general payments, 2019–2025

Across 142 payments — averaging $118.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$4K
  • Stryker$3K
  • Integra Lifesciences Corporation$3K
  • Smith+Nephew$2K
  • Medline Industries LP$1K
  • Nvision Biomedical Technologies, Inc.$1K
  • plus $3K from 14 others

What the payments were for

  • Travel & lodging$11,89670%
  • Food & beverage$3,78322%
  • Education$1,2007%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,880 in reported general payments places this provider in the 95th percentile of 59 primary podiatric medicine providers in California.

See all primary podiatric medicine providers in California

Medicare billing

Part B allowed, 2024
$673,039
Medicare patients
137
Services billed
1,043

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate223$3,351
Diclofenac Sodium15$1,251
Cephalexin244$802
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip21$534
Ketoconazole18$361
Doxycycline Hyclate73$350
Meloxicam135$280
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav34$232
Gabapentin57$221
Celecoxib11$129
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim45$112
Methylprednisolone12$71
Mupirocin12$63

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Bakersfield

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →